• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Reclassification of predictions for uncovering subgroup specific improvement.重新分类预测以揭示亚组特异性改善。
Stat Med. 2014 May 20;33(11):1914-27. doi: 10.1002/sim.6077. Epub 2013 Dec 18.
2
Simpson's paradox in the integrated discrimination improvement.综合鉴别改善中的辛普森悖论。
Stat Med. 2017 Dec 10;36(28):4468-4481. doi: 10.1002/sim.6862. Epub 2016 Jan 5.
3
Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO.评估乳腺肿瘤标志物在 BRCAPro 遗传风险预测模型中的附加价值。
Breast Cancer Res Treat. 2012 May;133(1):347-55. doi: 10.1007/s10549-012-1958-z. Epub 2012 Jan 21.
4
Simplifying clinical use of the genetic risk prediction model BRCAPRO.简化遗传风险预测模型 BRCAPRO 的临床应用。
Breast Cancer Res Treat. 2013 Jun;139(2):571-9. doi: 10.1007/s10549-013-2564-4. Epub 2013 May 21.
5
A two-stage approach to genetic risk assessment in primary care.基层医疗中遗传风险评估的两阶段方法。
Breast Cancer Res Treat. 2016 Jan;155(2):375-83. doi: 10.1007/s10549-016-3686-2. Epub 2016 Jan 19.
6
10-year performance of four models of breast cancer risk: a validation study.四种乳腺癌风险模型的 10 年表现:一项验证研究。
Lancet Oncol. 2019 Apr;20(4):504-517. doi: 10.1016/S1470-2045(18)30902-1. Epub 2019 Feb 21.
7
Interpreting incremental value of markers added to risk prediction models.解读风险预测模型中新增标志物的增量价值。
Am J Epidemiol. 2012 Sep 15;176(6):473-81. doi: 10.1093/aje/kws207. Epub 2012 Aug 8.
8
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.风险顾问和计算机模型BRCAPRO对BRCA1或BRCA2突变的检测前预测。
J Natl Cancer Inst. 2002 Jun 5;94(11):844-51. doi: 10.1093/jnci/94.11.844.
9
Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent.BRCA1和BRCA2突变携带者预测模型在法裔加拿大血统乳腺癌和/或卵巢癌家族中的应用。
Clin Genet. 2006 Oct;70(4):320-9. doi: 10.1111/j.1399-0004.2006.00673.x.
10
Practical implementation of frailty models in Mendelian risk prediction.实用实施脆弱性模型在孟德尔风险预测。
Genet Epidemiol. 2020 Sep;44(6):564-578. doi: 10.1002/gepi.22323. Epub 2020 Jun 7.

引用本文的文献

1
Early detection of ICU-acquired infections using high-frequency electronic health record data.利用高频电子健康记录数据早期检测重症监护病房获得性感染
BMC Med Inform Decis Mak. 2025 Jul 21;25(1):273. doi: 10.1186/s12911-025-03031-6.
2
Genome-wide polygenic risk scores predict risk of glioma and molecular subtypes.全基因组多基因风险评分可预测胶质瘤风险及分子亚型。
Neuro Oncol. 2024 Oct 3;26(10):1933-1944. doi: 10.1093/neuonc/noae112.
3
Simpson's paradox in the integrated discrimination improvement.综合鉴别改善中的辛普森悖论。
Stat Med. 2017 Dec 10;36(28):4468-4481. doi: 10.1002/sim.6862. Epub 2016 Jan 5.
4
Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themes.评估替代终点、预后标志物和预测标志物:一些简单的主题。
Clin Trials. 2015 Aug;12(4):299-308. doi: 10.1177/1740774514557725. Epub 2014 Nov 10.
5
How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through.如何解释 AUC 随着额外风险预测标志物的增加而略有增加:决策分析派上用场。
Stat Med. 2014 Sep 28;33(22):3946-59. doi: 10.1002/sim.6195. Epub 2014 May 13.

本文引用的文献

1
A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.关于新型生物标志物评估的一则注释:不要依赖综合判别改善和净重新分类指数。
Stat Med. 2014 Aug 30;33(19):3405-14. doi: 10.1002/sim.5804. Epub 2013 Apr 2.
2
Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO.评估乳腺肿瘤标志物在 BRCAPro 遗传风险预测模型中的附加价值。
Breast Cancer Res Treat. 2012 May;133(1):347-55. doi: 10.1007/s10549-012-1958-z. Epub 2012 Jan 21.
3
Problems with risk reclassification methods for evaluating prediction models.评估预测模型的风险重新分类方法存在问题。
Am J Epidemiol. 2011 Jun 1;173(11):1327-35. doi: 10.1093/aje/kwr013. Epub 2011 May 9.
4
Performance of reclassification statistics in comparing risk prediction models.比较风险预测模型时重新分类统计的性能
Biom J. 2011 Mar;53(2):237-58. doi: 10.1002/bimj.201000078. Epub 2011 Feb 3.
5
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.将净重新分类改进计算扩展到测量新生物标志物的有用性。
Stat Med. 2011 Jan 15;30(1):11-21. doi: 10.1002/sim.4085. Epub 2010 Nov 5.
6
Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures.心血管风险个体预测因素效应测量的进展:重新分类测量的作用。
Ann Intern Med. 2009 Jun 2;150(11):795-802. doi: 10.7326/0003-4819-150-11-200906020-00007.
7
Tailoring BRCAPRO to Asian-Americans.为亚裔美国人量身定制BRCAPRO。
J Clin Oncol. 2009 Feb 1;27(4):642-3; author reply 643-4. doi: 10.1200/JCO.2008.20.6896. Epub 2008 Dec 15.
8
Genotype score in addition to common risk factors for prediction of type 2 diabetes.除常见风险因素外,基因型评分对2型糖尿病的预测作用
N Engl J Med. 2008 Nov 20;359(21):2208-19. doi: 10.1056/NEJMoa0804742.
9
Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction.将肿瘤免疫组化标志物纳入BRCA1和BRCA2携带者预测中。
Breast Cancer Res. 2008;10(2):401. doi: 10.1186/bcr1866. Epub 2008 Mar 20.
10
Multiple diseases in carrier probability estimation: accounting for surviving all cancers other than breast and ovary in BRCAPRO.携带者概率估计中的多种疾病:BRCAPRO中除乳腺癌和卵巢癌外其他所有癌症幸存者的考量。
Stat Med. 2008 Sep 30;27(22):4532-48. doi: 10.1002/sim.3302.

重新分类预测以揭示亚组特异性改善。

Reclassification of predictions for uncovering subgroup specific improvement.

作者信息

Biswas Swati, Arun Banu, Parmigiani Giovanni

机构信息

Department of Mathematical Sciences, University of Texas at Dallas, Richardson, TX 75080-3021, U.S.A.

出版信息

Stat Med. 2014 May 20;33(11):1914-27. doi: 10.1002/sim.6077. Epub 2013 Dec 18.

DOI:10.1002/sim.6077
PMID:24353130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4008681/
Abstract

Risk prediction models play an important role in prevention and treatment of several diseases. Models that are in clinical use are often refined and improved. In many instances, the most efficient way to improve a successful model is to identify subgroups for which there is a specific biological rationale for improvement and tailor the improved model to individuals in these subgroups, an approach especially in line with personalized medicine. At present, we lack statistical tools to evaluate improvements targeted to specific subgroups. Here, we propose simple tools to fill this gap. First, we extend a recently proposed measure, the Integrated Discrimination Improvement, using a linear model with covariates representing the subgroups. Next, we develop graphical and numerical tools that compare reclassification of two models, focusing only on those subjects for whom the two models reclassify differently. We apply these approaches to BRCAPRO, a genetic risk prediction model for breast and ovarian cancer, using data from MD Anderson Cancer Center. We also conduct a simulation study to investigate properties of the new reclassification measure and compare it with currently used measures. Our results show that the proposed tools can successfully uncover subgroup specific model improvements.

摘要

风险预测模型在多种疾病的预防和治疗中发挥着重要作用。临床使用的模型通常会不断完善和改进。在许多情况下,改进一个成功模型的最有效方法是识别那些有特定生物学依据可改进的亚组,并针对这些亚组中的个体调整改进后的模型,这种方法特别符合个性化医疗。目前,我们缺乏评估针对特定亚组改进情况的统计工具。在此,我们提出了一些简单工具来填补这一空白。首先,我们使用一个带有代表亚组协变量的线性模型,扩展了最近提出的一种度量方法——综合鉴别改进。接下来,我们开发了图形和数值工具,用于比较两个模型的重新分类情况,只关注那些两个模型重新分类不同的受试者。我们将这些方法应用于BRCAPRO,这是一种用于乳腺癌和卵巢癌的遗传风险预测模型,使用了来自MD安德森癌症中心的数据。我们还进行了一项模拟研究,以调查新的重新分类度量方法的特性,并将其与目前使用的度量方法进行比较。我们的结果表明,所提出的工具能够成功揭示亚组特异性的模型改进情况。